Neuroblastoma Patients With ARID1A And ARID1B Mutations Have More Aggressive Disease

In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes...



Cancer-Medicine in USA